viewLexaGene Holdings Inc.

LexaGene hires two salespeople to tackle diagnostic and vet market with new MiQLab analyzers

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has made two key sales hires as they look to begin to roll out their genetic analyzers for rapid pathogen detection called MiQLab.

Regan says they are hiring in the diagnostic and veterinarian space which will be two very key markets for the company. Regan also told Proactive they have exercised 99% of their warrants and brought in a large amount of cash for the treasury.

Quick facts: LexaGene Holdings Inc.

Price: 1.28 CAD

Market: TSX-V
Market Cap: $145.55 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...


LexaGene starts program to Identify UK and South African COVID Sequences

Lexagene Holdings (CVE: LXG- OTCQB: LXXGF) CEO Jack Regan joined Steve Darling from Proactive with news the company is planning to use their patented MiQLa system to investigate novel variants of the SARS-Cov-2 which is the pathogen that causes COVID-19. Dr. Regan telling Proactive this...

1 day, 20 hours ago

2 min read